Senti Biosciences Holdings, Inc.
Senti Biosciences Holdings, Inc. scores highest on Earnings (44) and lowest on Price (0). Its PosiPenta is 19.99 out of 100, clearly weaker than most similar companies.
On the Penta Grid this week, Senti Biosciences Holdings, Inc. is Grid #831 of 837 in the Healthcare sector in United States, and Grid #3,940 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Senti Biosciences Holdings, Inc. | 19.99 | 0 | 44 | 10 | 6 | 40 |
| Creative Medical Technology Holdings, Inc. | 40.72 | 44 | 46 | 18 | 59 | 37 |
| Moleculin Biotech, Inc. | 43.19 | 95 | 48 | 9 | 34 | 30 |
| Tenon Medical, Inc. | 22.28 | 0 | 35 | 10 | 35 | 31 |
| Niki BioSolutions, Inc. | 35.00 | 48 | 25 | 12 | 52 | 37 |
| Healthcare Triangle, Inc. | 34.39 | 50 | 40 | 1 | 42 | 39 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.13 |
| P/B ratio | -2.06 |
EEarnings
| Trailing EPS | ₹-162.91 |
| Forward EPS | ₹-89.98 |
NNitro
| Price | 21.30 |
| 52-week high | 272.78 |
| 52-week low | 20.10 |
| Fall from 52-week high | 92.2% |
TTorque
| Return on equity (ROE) | -466.46% |
| Debt-to-equity | 5.17 |
AAnchor
| Beta (price swings) | 2.22 |
| Market cap | ₹66 Cr |
| Insider holding | 48.43% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Senti Biosciences Holdings, Inc.'s PosiPenta score?
Senti Biosciences Holdings, Inc.'s PosiPenta is 19.99 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Senti Biosciences Holdings, Inc. stand on the Penta Grid?
On the Penta Grid this week, Senti Biosciences Holdings, Inc. is Grid #831 of 837 in the Healthcare sector in United States, and Grid #3,940 of 4,000 in United States.
Which PosiPenta pillar is strongest for Senti Biosciences Holdings, Inc.?
Earnings (growth), with a score of 44 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Senti Biosciences Holdings, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.